Conversely, the TGFβ pathway showed greater activation in MSS tumors and has been associated with epithelial‐to‐mesenchymal transition (EMT), metastasis, and therapy resistance [102, 103]. This evidence concerns the gene TGFB1 and Marinesco-Sjogren syndrome.